What Led to the Sealing of a Pharma Agency in Raebareli?

Synopsis
Key Takeaways
- 1.4 lakh bottles of codeine syrup were illegally purchased.
- The Ajay Pharma Agency was sealed by authorities.
- Codeine poses serious health risks, including addiction.
- Legal action is being pursued against the operator.
- This incident is part of a larger crackdown on unsafe pharmaceuticals.
Raebareli, Oct 14 (NationPress) Authorities have taken decisive action by sealing a pharmaceutical agency in Raebareli, Uttar Pradesh, after it was found to have unlawfully acquired 1.40 lakh bottles of codeine-based cough syrup, a controlled substance notorious for its addictive nature and dangerous consequences.
The agency, known as Ajay Pharma Agency, was sealed following a comprehensive raid led by a team of drug inspectors.
Codeine, an opioid used in certain cough syrups, carries significant health hazards, including addiction, respiratory failure, overdose, and potential death.
Authorities stated that the syrup stock had been sourced from Indica Life Sciences, located in Lucknow's Transport Nagar.
Prior to the raid, the agency's operator reportedly secured the premises and absconded. Legal proceedings are being initiated against the operator who fled.
Drug Inspector Shivendra Pratap Singh, who led the operation, confirmed the sealing of the premises and indicated that legal actions are forthcoming.
In a statement to IANS, he mentioned, "We received intelligence regarding a substantial supply of the narcotic codeine cough syrup from Ghaziabad Pharma via Lucknow. Upon arrival, we found the shop closed. The owner was notified to report."
"After a thorough investigation, we will ensure stringent measures are taken against the accused," he added.
This crackdown coincides with a nationwide initiative targeting pharmaceutical agencies involved in the sale or distribution of unfit medications, following the tragic deaths of several children in Madhya Pradesh linked to the contaminated Coldrif cough syrup.
The Tamil Nadu government has permanently revoked the manufacturing license of Sresan Pharmaceuticals, the producer of the adulterated Coldrif, and ordered its complete closure due to findings that the product contained dangerously high levels of toxic substances.
The Tamil Nadu government issued a statement saying, "The drug manufacturing license of Sresan Pharmaceuticals has been fully revoked, and the company has been shut down. We have also mandated a comprehensive inspection of all drug manufacturing facilities across Tamil Nadu to ensure adherence to safety and quality standards."
Officials revealed that the Health Department will enhance monitoring protocols and implement stricter penalties for pharmaceutical companies that violate public health regulations.
During an inspection of the Kancheepuram facility of Sresan Pharmaceuticals, authorities discovered that Coldrif syrup contained 48.6 percent diethylene glycol (DEG), a hazardous industrial solvent utilized in antifreeze, instead of the appropriate pharmaceutical components.
The consumption of this syrup has been associated with the deaths of over 20 children in the Chhindwara district of Madhya Pradesh, sparking national outrage and scrutiny.